Fundamental Weaknesses in the CRM Programmes of UK Pharmaceutical Companies

This paper summarises findings from an ongoing research programme by customer management specialists White Whale into the state of CRM in UK Pharmaceutical companies. It concludes companies’ programmes are failing to generate increased value for customers and to focus on those customers offering the greatest returns. Consequently it warns there is a serious risk such programmes will fail to produce significant business benefit.